Loomis, Sayles & Company
EW icon

Loomis, Sayles & Company’s Edwards Lifesciences EW Stock Holding History

Loomis, Sayles & Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-548
Closed -$36K – 747
2024
Q3 		$36K Buy
548
+10
+2% +$727 ﹤0.01% 659
2024
Q2 		$50K Buy
538
+11
+2% +$974 ﹤0.01% 632
2024
Q1 		$50K Sell
527
-6
-1% -$504 ﹤0.01% 618
2023
Q4 		$41K Sell
533
-415
-44% -$28.9K ﹤0.01% 623
2023
Q3 		$66K Buy
948
+93
+11% +$7.47K ﹤0.01% 569
2023
Q2 		$81K Buy
855
+408
+91% +$35.5K ﹤0.01% 552
2023
Q1 		$37K Sell
447
-157
-26% -$12.3K ﹤0.01% 666
2022
Q4 		$45K Buy
604
+448
+287% +$34.5K ﹤0.01% 622
2022
Q3 		$13K Sell
156
-879
-85% -$84.6K ﹤0.01% 650
2022
Q2 		$98K Sell
1,035
-223
-18% -$23.1K ﹤0.01% 545
2022
Q1 		$148K Buy
1,258
+23
+2% +$2.58K ﹤0.01% 568
2021
Q4 		$160K Hold
1,235
– – ﹤0.01% 576
2021
Q3 		$140K Hold
1,235
– – ﹤0.01% 553
2021
Q2 		$128K Sell
1,235
-16
-1% -$1.51K ﹤0.01% 554
2021
Q1 		$105K Hold
1,251
– – ﹤0.01% 554
2020
Q4 		$114K Hold
1,251
– – ﹤0.01% 526
2020
Q3 		$100K Hold
1,251
– – ﹤0.01% 537
2020
Q2 		$86K Buy
1,251
+21
+2% +$1.49K ﹤0.01% 531
2020
Q1 		$77K Hold
1,230
– – ﹤0.01% 542
2019
Q4 		$96K Buy
+1,230
New +$96K ﹤0.01% 589

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Loomis, Sayles & Company's EW Position: Q4 2024 in Review

Loomis, Sayles & Company sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 548 shares — an estimated $36K sold.

Loomis, Sayles & Company first reported a position in EW in Q4 2019 and held it in 20 quarters. The position peaked at $160K in Q4 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Loomis, Sayles & Company reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 548 Edwards Lifesciences shares in Q4 2024, an estimated $36K.
  • Loomis, Sayles & Company first reported a position in Edwards Lifesciences in Q4 2019 and held it in 20 quarters.
  • Loomis, Sayles & Company's Edwards Lifesciences position peaked at $160K in Q4 2021.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.